Vortioxetine improves gastrointestinal motility and reduces intestinal inflammation in a cuprizone-induced multiple sclerosis model in mice. Ann Med Res [Internet]. 2026 May 22 [cited 2026 Jun. 1];33(5):192-8. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4909